ArticleFrontiers in immunology2024

PD-1 inhibitor combined with paclitaxel and cisplatin in the treatment of recurrent and metastatic hypopharyngeal/laryngeal squamous cell carcinoma: efficacy and survival outcomes.

Qi Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.